Author Review — inspect what researchers actually reported

Visual summary — publication & citation footprint

Data source: OpenAlex author profile counts_by_year (works_count and cited_by_count aggregated per year) — this reveals citation spikes in 2017–2020 consistent with authorship on multiple high-impact CRISPR papers and diagnostics work.

Source (OpenAlex summary): citation and works counts by year used to make the figure below.

Key high-impact works (examples & interpretation)

• Science review (2018) — "CRISPR-Cas guides the future of genetic engineering" (first author Gavin J. Knott). This is a synthesis/review in Science that consolidates CRISPR diversity and applications; high citation count indicates influential conceptual contribution rather than a single experimental advance.
  Science CRISPR review (2018)
• Cell diagnostics paper (2020) — collaborative work on Cas13-based amplification-free SARS-CoV-2 detection with phone microscopy; demonstrates applied translational impact during the COVID-19 pandemic and cross-disciplinary methods.
  Cell CRISPR diagnostic (2020)
• Other collaborative high-visibility contributions include work on CRISPR-CasΦ, CasX family characterization, and accelerated CRISPR detection chemistry — many are multi-lab collaborations with first/last authors from leading groups (e.g., Doudna lab), indicating Knott's role as a significant contributor within strong teams.
  Science CasΦ paper (2020)

Reconciliation of author metrics (apparent discrepancy)

You were given two sets of metrics: (A) a short author summary (h-index 5, citations 125, 12 papers) and (B) OpenAlex (h-index 27, cited_by_count 6996, works_count 72). Discrepancies arise because different aggregators (OpenAlex, Semantic Scholar, Google Scholar, institutional pages) use different inclusion rules (what counts as "work", whether shared authorships are included, and how citations are aggregated). OpenAlex shows broad visibility likely reflecting inclusion of multiple high-citation collaborative works; the smaller counts likely reflect a filtered local dataset (12 papers) or an outdated snapshot.

Implication: rely on authoritative aggregator(s), cross-check primary DOIs listed above, and clarify whether you want per-paper author-position metrics (first/last) or total co-authorship tallies.

Strengths (evidence-based)

• Documented authorship on several high-impact journal articles (Science, Cell, Nature) that influenced CRISPR biology and diagnostics, indicating substantive domain expertise and collaborative leadership. Science review (2018)
• Contributions cover both mechanistic CRISPR biology and translational tools (e.g., Cas13 diagnostics), demonstrating breadth from basic to applied science. Cell diagnostics (2020)
• Frequent collaborative co-authorship with leading labs (e.g., Doudna) increases access to resources, data, and high-quality peer review.

Limitations, blindspots, and potential biases

• Many high-citation items are collaborative; disentangling the unique intellectual/experimental contribution of a middle-author vs first/last requires reading methods/author-contribution statements (often missing). Aggregated citation counts can overstate an individual’s independent impact.
• Review articles (e.g., Science review) accrue citations rapidly but reflect synthesis rather than new primary data — high citations do not equate to original experimental rigor alone.
• Aggregator differences (OpenAlex vs shorter author summary) show metadata/duplication/inclusion biases — cross-check institutional CV, ORCID, and publisher records for precise counts.
• No institutional affiliation consistently provided in your initial author summary; lack of current affiliation record can make evaluation of lab leadership and funding context harder.

Practical recommendations (for evaluators or collaborators)

1. Verify per-paper contribution: check author contributions and methods sections of key DOIs above to attribute responsibilities (experimental design, data analysis, writing).
2. Use multiple aggregators (OpenAlex, PubMed, Scopus if available, ORCID) and direct DOI checks to reconcile counts and h-index estimates.
3. For hiring/awards: weight first/last author primary-data contributions and independent grant/PI records more than cumulative co-authorship citation totals.
4. To probe reproducibility and rigor: request raw data, code, and methods for key experimental papers; inspect methods for controls and sample sizes.

Primary sources used (examples)

• Science review (2018)
• Cell diagnostics (2020)
• Science CasΦ (2020)
• OpenAlex profile (Knott)